FSM Wealth Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Buy
11,184
+660
+6% +$58.9K 0.12% 98
2026
Q1
$756K Buy
10,524
+29
+0.3% +$2.23K 0.1% 120
2025
Q4
$833K Buy
10,495
+292
+3% +$23K 0.11% 100
2025
Q3
$769K Buy
10,203
+289
+3% +$19.8K 0.11% 114
2025
Q2
$661K Buy
+9,914
New +$650K 0.11% 122
2023
Q2
Sell
-2,889
Closed -$215K 169
2023
Q1
$215K Buy
2,889
+174
+6% +$14.6K 0.12% 144
2022
Q4
$253K Buy
2,715
+16
+0.6% +$1.54K 0.18% 119
2022
Q3
$257K Buy
+2,699
New +$267K 0.21% 110

Other funds holding CVS

FSM Wealth Advisors's CVS Position: Q2 2026 in Review

FSM Wealth Advisors increased its CVS Health (CVS) stake by 6.3% in Q2 2026, buying an estimated $58.9K and bringing the position to 11,184 shares worth $1.16M. The position accounts for 0.12% of the portfolio, ranked #98.

FSM Wealth Advisors first reported a position in CVS in Q3 2022 and has held it in 8 quarters since. 1,199 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • FSM Wealth Advisors held 11,184 shares of CVS Health worth $1.16M as of Q2 2026.
  • FSM Wealth Advisors bought 660 CVS Health shares in Q2 2026, an estimated $58.9K.
  • CVS Health made up 0.12% of FSM Wealth Advisors's portfolio in Q2 2026, its #98 holding.
  • FSM Wealth Advisors first reported a position in CVS Health in Q3 2022 and has held it in 8 quarters since.
  • 1,199 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on FSM Wealth Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.